[Federal Register: December 11, 2007 (Volume 72, Number 237)]
[Notices]               
[Page 70344]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr11de07-67]                         

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Importer of Controlled Substances; Notice of Registration

    By Notice dated July 31, 2007 and published in the Federal Register 
on August 9, 2007, (72 FR 44859-44860), Aptuit (Allendale), Inc., 75 
Commerce Drive, Allendale, New Jersey 07401, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as an importer of Noroxymorphone (9668), a basic class of controlled 
substance listed in schedule II.
    The company plans to import the basic class of controlled substance 
for clinical trials and research.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of Aptuit (Allendale), Inc. to import the basic class of 
controlled substance is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971, at this time. DEA has investigated 
Aptuit (Allendale), Inc. to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 952(a) and Sec.  958(a), and in accordance with 21 CFR 
1301.34, the above named company is granted registration as an importer 
of the basic class of controlled substance listed.

     Dated: October 31, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E7-23978 Filed 12-10-07; 8:45 am]

BILLING CODE 4410-09-P